Health & Medicine Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health & Medicine Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alzheimer Disease
Study finds a 39% reduction in AD in patients taking statin drugs
March 22nd, 2004
Patients taking cholesterol-lowering statin drugs had a 39% lower risk of acquiring Alzheimer disease (AD) according to a recent study published in Neuroepidemiology (2004;23:94-8). The study by a team of researchers at the School of Medicine, University of Alabama at Birmingham, Alabama examined the medical records of more than 3300 patients at a Veterans Affairs Medical Center over a 4-year period. The study found a statistically significant reduction in AD risk in statin users. "Nymox holds U.S. and global patent rights for the use of statins for the prevention and treatment of AD," said Dr. Michael Munzar, medical director of Nymox. "We...
Source: Health & Medicine Week (2004-03-22)
|
